- Home
- TSHA vs TRNS Comparison
TSHA vs TRNS Comparison
Compare TSHA & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- TRNS
- Stock Information
- Founded
- TSHA 2019
- TRNS 1964
- Country
- TSHA United States
- TRNS United States
- Employees
- TSHA N/A
- TRNS N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- TRNS Electrical Products
- Sector
- TSHA Health Care
- TRNS Industrials
- Exchange
- TSHA Nasdaq
- TRNS Nasdaq
- Market Cap
- TSHA 728.4M
- TRNS 748.7M
- IPO Year
- TSHA 2020
- TRNS N/A
- Fundamental
- Price
- TSHA $2.65
- TRNS $84.15
- Analyst Decision
- TSHA Strong Buy
- TRNS Buy
- Analyst Count
- TSHA 6
- TRNS 4
- Target Price
- TSHA $8.17
- TRNS $108.67
- AVG Volume (30 Days)
- TSHA 2.6M
- TRNS 98.5K
- Earning Date
- TSHA 08-11-2025
- TRNS 08-06-2025
- Dividend Yield
- TSHA N/A
- TRNS N/A
- EPS Growth
- TSHA N/A
- TRNS N/A
- EPS
- TSHA N/A
- TRNS 1.57
- Revenue
- TSHA $7,224,000.00
- TRNS $278,421,000.00
- Revenue This Year
- TSHA N/A
- TRNS $10.82
- Revenue Next Year
- TSHA N/A
- TRNS $6.52
- P/E Ratio
- TSHA N/A
- TRNS $53.14
- Revenue Growth
- TSHA N/A
- TRNS 7.30
- 52 Week Low
- TSHA $1.05
- TRNS $67.56
- 52 Week High
- TSHA $3.31
- TRNS $147.12
- Technical
- Relative Strength Index (RSI)
- TSHA 56.06
- TRNS 51.41
- Support Level
- TSHA $2.34
- TRNS $80.40
- Resistance Level
- TSHA $2.81
- TRNS $85.08
- Average True Range (ATR)
- TSHA 0.16
- TRNS 3.03
- MACD
- TSHA 0.01
- TRNS -0.30
- Stochastic Oscillator
- TSHA 67.37
- TRNS 39.64
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and distribution of test, measurement, and control instrumentation. Its product and services portfolio consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, etc. The firm has Service and Distribution operating segments. It derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Estech, FLIR, Fluke, Keysight, and Megger among others. It serves to pharmaceutical, industrial manufacturing, energy, and chemical process industries.